Back to Search
JOHN BOHNERT, M.D.
M.D.
Anesthesiology Physician
NPI: 1558351577IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
8353(MT)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 1988
Research & Publications (12)
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
PMID 18936189·Antimicrob Agents Chemother·2009
8-other
Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB.
PMID 18849422·J Bacteriol·2008
8-other
Preventive ablation strategies in a biophysical model of atrial fibrillation based on realistic anatomical data.
PMID 18269975·IEEE Trans Biomed Eng·2008
8-other
Multiple wavelets, rotors, and snakes in atrial fibrillation--a computer simulation study.
PMID 17336996·J Electrocardiol·2007
8-other
Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
PMID 17062614·J Antimicrob Chemother·2007
8-other
Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation.
PMID 16971414·J Antimicrob Chemother·2007
8-other
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide.
PMID 16531429·J Antimicrob Chemother·2006
4-observational
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
PMID 16354747·J Antimicrob Chemother·2006
8-other
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli.
PMID 16354746·J Antimicrob Chemother·2006
8-other
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
PMID 15714332·Eur J Clin Microbiol Infect Dis·2005
8-other
Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.
PMID 15673787·Antimicrob Agents Chemother·2005
8-other
Rapid identification of Enterobacteriaceae using a novel 23S rRNA-targeted oligonucleotide probe.
PMID 10956593·Int J Hyg Environ Health·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3550 MULLAN RD, SUITE 103
MISSOULA, MT 59808 - Phone
- (406) 728-8420
Quick Facts
- NPI
- 1558351577
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 12
Are you this provider?
Claim Your Profile